Yüklüyor......
Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
Key cytotoxic drugs of chemotherapy for gastroesophageal cancer include fluoropyrimidine, platinum, taxanes and irinotecan. Concurrent chemoradiotherapy is one of the main treatment strategies, especially for esophageal cancer. As molecular target agents, the anti-HER2 antibody trastuzumab for HER2-...
Kaydedildi:
| Yayımlandı: | World J Gastrointest Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657220/ https://ncbi.nlm.nih.gov/pubmed/31367271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v11.i7.518 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|